Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital

BACKGROUND: Apart from reducing occupational exposure to cytotoxic hazards, the PhaSeal® closed-system transfer device (CSTD) can extend the beyond-use dates (BUDs) of unfinished vials of antineoplastic drugs for up to 168 hours (seven days). In this study, the total material cost incurred by its us...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Huan Keat, Lim, Yik Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454702/
https://www.ncbi.nlm.nih.gov/pubmed/28032722
http://dx.doi.org/10.22034/APJCP.2016.17.11.4951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454702/
https://www.ncbi.nlm.nih.gov/pubmed/28032722
http://dx.doi.org/10.22034/APJCP.2016.17.11.4951

Ejemplares similares